Status:
COMPLETED
AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184
Lead Sponsor:
Shire
Conditions:
Healthy
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
To evaluate how the body absorbs, metabolizes (breaks down) and excretes (eliminates) the study drug. Further, the study will determine how much of the study drug gets into the bloodstream and how lon...
Eligibility Criteria
Inclusion
- Healthy adult male subjects aged between 18 and 65 years inclusive
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2013
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01824446
Start Date
May 1 2013
End Date
May 29 2013
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Covance Clinical Research Unit Inc
Madison, Wisconsin, United States, 53704